| Name | Support | Language | Availability | Edition date | Price | ||
|---|---|---|---|---|---|---|---|
|
PDF |
English |
Active |
6/21/2022 |
€193.00 |
|
||
Details
This document provides guidance to the clinical laboratorian for the reduction of interlaboratory variance and the evaluation of interferences, assay performance, and other pertinent characteristics of clinical assays. This guideline emphasizes particular areas related to assay development and presents a standardized approach for method verification that is specific to mass spectrometry technology.
Additional Info
| Author | Clinical and Laboratory Standards Institute (CLSI) |
|---|---|
| Published by | CLSI |
| Document type | Standard |
| Theme | /subgroups/17901 |
| EAN ISBN | 9781684401550 |
| Number of pages | 104 |
| Replace | CLSI C62-A |
| Keyword | CLSI C62 |
